Evidence map›Paper›PMID 42130650›Full record

ArticleEuropean heart journal. Case reports2026

Case report: VA-ECMO as a bridge to collapse in carcinoid heart disease.

Ana Alicia Alañón Hernández, Javier Tobar Ruiz, Jose Francisco Gil Fernandez, Javier García de Casasola Rodriguez, Maria Plaza Martín

Abstract readCase Reports
In one paragraph

Article in European heart journal. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ana Alicia Alañón HernándezDepartment of Cardiology, Hospital Clínico Universitario de Valladolid, Avenida de Ramón y Cajal 3, 47003 Valladolid (Castilla y León), Spain.ORCID https://orcid.org/0009-0006-8954-6000
Javier Tobar RuizDepartment of Cardiology, Hospital Clínico Universitario de Valladolid, Avenida de Ramón y Cajal 3, 47003 Valladolid (Castilla y León), Spain.
Jose Francisco Gil FernandezDepartment of Cardiology, Hospital Clínico Universitario de Valladolid, Avenida de Ramón y Cajal 3, 47003 Valladolid (Castilla y León), Spain.
Javier García de Casasola RodriguezDepartment of Cardiology, Hospital Clínico Universitario de Valladolid, Avenida de Ramón y Cajal 3, 47003 Valladolid (Castilla y León), Spain.
Maria Plaza MartínDepartment of Cardiology, Hospital Clínico Universitario de Valladolid, Avenida de Ramón y Cajal 3, 47003 Valladolid (Castilla y León), Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Carcinoid heart disease is a rare complication of neuroendocrine tumours caused by chronic exposure to vasoactive substances, leading to progressive valvular dysfunction and right heart failure. The use of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) in this context remains controversial, as it may exacerbate carcinoid crisis by bypassing the pulmonary metabolism of these vasoactive mediators. Case summary: We describe a patient with clinical suspicion of a neuroendocrine tumour and severe carcinoid heart disease who developed refractory cardiogenic shock. VA-ECMO was initiated as rescue support but resulted in an abrupt haemodynamic collapse, the patient subsequently progressed to multiorgan failure and died. This case illustrates the paradoxical and potentially deleterious effects of extracorporeal support in the setting of carcinoid physiology. Discussion: In the setting of a carcinoid crisis with cardiogenic shock secondary to right ventricular failure, VA-ECMO may appear as a potential option for haemodynamic support. However, by reducing pulmonary blood flow-and consequently the degradation of vasoactive substances-its use may worsen the patient's clinical condition. Therefore, a multidisciplinary approach involving cardiology, acute cardiac care, intensive care, oncology, gastroenterology, endocrinology, and pathology teams is essential, both in diagnosis and management.

Indexed as

Carcinoid heart diseaseCase reportMechanical circulatory supportNeuroendocrine tumourRight ventricular failureVeno-arterial extracorporeal membrane oxygenation (VA-ECMO)

Identifiers

PMID42130650
PMCPMC13165416

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.